Homocysteinemia and endothelial damage after methionine load

J Hladovec1, Z Sommerová, A Písaríková

  • 14th Medical Clinic, Medical Faculty, Charles University, Prague, Czech Republic.

Thrombosis Research
|April 4, 1998
PubMed

Insights

Elevated homocysteine levels in peripheral artery disease patients indicate a threshold for endothelial damage. A higher methionine load was needed to significantly increase circulating endothelial cells, suggesting a dose-dependent effect on vascular health.

Area of Science:

  • Vascular Biology
  • Cardiovascular Research
  • Metabolic Studies

Background:

  • Peripheral artery occlusive disease (PAOD) is linked to endothelial dysfunction.
  • Homocysteine is a potential contributor to vascular damage.
  • Circulating endothelial cells (CECs) serve as a marker for endothelial injury.

Purpose of the Study:

  • To investigate the relationship between homocysteine levels and endothelial damage in PAOD patients.
  • To determine the threshold of homocysteine concentration required to induce endothelial lesions.
  • To assess the impact of varying methionine loads on CECs in PAOD.

Main Methods:

  • Patients with PAOD received methionine loads of 50 mg/kg and 100 mg/kg.
  • Blood samples were analyzed for homocysteine concentrations.
  • Circulating endothelial cell counts were measured as a marker of endothelial damage.

Main Results:

  • A 50 mg/kg methionine load significantly increased homocysteine but did not elevate CECs.
  • A 100 mg/kg methionine load markedly increased both homocysteine and CECs.
  • These findings suggest a threshold homocysteine level is necessary for endothelial lesion induction.

Conclusions:

  • Homocysteine elevation above a specific threshold is critical for inducing endothelial damage in PAOD.
  • Methionine load is a useful tool to study homocysteine-induced endothelial injury.
  • Understanding this threshold may inform therapeutic strategies for PAOD.

Related Concept Videos

Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Sulfur Assimilation01:20

Sulfur Assimilation

Sulfur is an essential element in biological systems, contributing to synthesizing key biomolecules, including amino acids such as cysteine and methionine, and cofactors such as coenzyme A and biotin. Microorganisms primarily assimilate sulfur as sulfate (SO₄²⁻) from the environment, which must undergo a series of biochemical transformations before it can be incorporated into cellular components. As sulfate is highly oxidized, it must undergo assimilatory sulfate reduction to become...